The briefing
A review explores whether cell therapies such as CAR-T, TCR-T, and TIL can succeed in solid tumors. It discusses neoantigen targeting, locoregional delivery, and strategies to overcome the tumor microenvironment.
Original headline
The Big Questions in Cancer Immunotherapy: Can Cell Therapy Succeed in Solid Tumors?